May 26, 2020 - TRIAL-IN Pharma

Halaven plus Keytruda for metastatic Triple Negative Breast Cancer

Triple Negative Breast Cancer: Halaven plus Keytruda

Post author:NIR EREZ
Post published:May 26, 2020
Post category:Breast Cancer

About the two study drugs in Triple Negative Breast Cancer Both study drugs are FDA approved. Halaven is approved for advanced breast cancer and Keytruda for different cancer indications. As…

Glioblastoma - Adding Keppra might improve treatment outcomes

Glioblastoma: Epilepsy drug plus standard treatment

Post author:NIR EREZ
Post published:May 26, 2020
Post category:Glioblastoma

Background about Glioblastoma Glioblastoma, GBM, is an aggressive and the most frequent malignant brain tumor primary brain tumor with poor prognosis. At diagnosis, the standard treatment is largely confined to…